Literature DB >> 13307092

Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man.

C M SOUTHAM, M R HILLEMAN, J H WERNER.   

Abstract

Entities:  

Keywords:  NEOPLASMS/pathology; VIRUSES

Mesh：

Year:  1956        PMID： 13307092

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  9 in total

1.  Acute respiratory illness in volunteers following intramuscular administration of live adenovirus.

Authors:  M R HILLEMAN; R E HODGES; M S WARFIELD; S A ANDERSON
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

2.  Discussion on adenovirus infections.

Authors:  B E ANDREWS; J C MCDONALD; H G PEREIRA; B KELLY
Journal:  Proc R Soc Med       Date:  1957-10

3.  The A.P.C. viruses.

Authors:  E ZAIMAN
Journal:  Postgrad Med J       Date:  1956-09       Impact factor: 2.401

Review 4.  Oncolytic virus as a cancer stem cell killer: progress and challenges.

Authors:  Jingzhen Ding
Journal:  Stem Cell Investig       Date:  2014-12-28

Review 5.  Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment.

Authors:  Saber Yezli; Jonathan A Otter
Journal:  Food Environ Virol       Date:  2011-03-16       Impact factor: 2.778

6.  Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus.

Authors:  Jason C Steel; Brian J Morrison; Poonam Mannan; Mones S Abu-Asab; Oliver Wildner; Brian K Miles; Kevin C Yim; Vijay Ramanan; Gregory A Prince; John C Morris
Journal:  Virology       Date:  2007-08-28       Impact factor: 3.616

Review 7.  Tumor Restrictions to Oncolytic Virus.

Authors:  Markus Vähä-Koskela; Ari Hinkkanen
Journal:  Biomedicines       Date:  2014-04-17

Review 8.  Oncolytic viruses in cancer therapy.

Authors:  Markus J V Vähä-Koskela; Jari E Heikkilä; Ari E Hinkkanen
Journal:  Cancer Lett       Date:  2007-03-23       Impact factor: 8.679

9.  Trial watch: Oncolytic viruses for cancer therapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-04-16       Impact factor: 8.110
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.